NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, has achieved a growing distinction and web-based presence, offering transparency in pharmaceutical purchasing. The company’s flagship Bonum+ platform provides subscribers with access to drug prices and supply availability, enabling them to make informed product ordering decisions. A recent article discussing this quotes Trxade Group founder, chairman and CEO Suren Ajjarapu, who states, “Our platform lets these independents know that they’re receiving a fair price from competing suppliers on fair payment terms and often with next day delivery. We believe this radical price transparency, economy of scale and competition amongst suppliers leads to up to a 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer